Pertuzumab: increasing the options. 

<br/><br/>Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - present 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0890-9091 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Antibodies, Monoclonal, Humanized/tu [Therapeutic Use]<br/>*Antineoplastic Agents/tu [Therapeutic Use]<br/>*Breast Neoplasms/dt [Drug Therapy]<br/>*Drug Approval<br/>*Receptor, erbB-2/ai [Antagonists & Inhibitors]<br/>Animals<br/>Female<br/>Humans
<br/><br/><label>Subjects--Geographic Terms: </label><br/>Washington Cancer Institute
<br/><br/><label>Index Terms--Function: </label><br/>Comment<br/>Journal Article<br/>Research Support, Non-U.S. Gov't